Synthesis and biological evaluation of 2,3-diarylimidazo[1,2-a]pyridines as antileishmanial agents

Models, Molecular Pyridines [SDV]Life Sciences [q-bio] Casein kinase 1 2 Antiprotozoal Agents Antineoplastic Agents Direct arylation 01 natural sciences Structure-Activity Relationship Parasitic Sensitivity Tests 615 Lipophilicity [CHIM] Chemical Sciences [CHIM]Chemical Sciences Humans Protein Kinase Inhibitors Protein Kinase C Antileishmanial activity 2 Cell Proliferation Leishmania major Dose-Response Relationship, Drug Molecular Structure Casein Kinase I Antileishmanial activity 540 0104 chemical sciences 3. Good health [SDV] Life Sciences [q-bio] [SDV.TOX] Life Sciences [q-bio]/Toxicology Antileishmanial activity 2 3-Diarylimidazo[1 2-a]pyridines Direct arylation Lipophilicity Casein kinase 1 [SDV.TOX]Life Sciences [q-bio]/Toxicology 3-Diarylimidazo[1 [SDV.SP.PHARMA] Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology 2-a]pyridines Direct arylation Lipophilicity Casein kinase 1 Drug Screening Assays, Antitumor 2-a]pyridines HeLa Cells
DOI: 10.1016/j.ejmech.2012.10.048 Publication Date: 2012-11-02T21:31:59Z
ABSTRACT
A novel series of 2,3-diarylimidazo[1,2-a]pyridines was synthesized and evaluated for their antileishmanial activities. Four derivatives exhibited good activity against the promastigote and intracellular amastigote stages of Leishmania major, coupled with a low cytotoxicity against the HeLa human cell line. The impact of compound lipophilicity on antiparasitic activities was investigated by Log D comparison. Although LmCK1 could be the parasitic target for three compounds (13, 18, 21), the inhibition of another target is under study to explain the antileishmanial effect of the most promising compounds.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (36)
CITATIONS (61)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....